Swing Modernization Toolkit addresses a growing challenge for enterprises: millions of lines of business-critical Java Swing code that still work but face increasing pressure from users who expect ...
ASP.NET Core in .NET 11 Preview 1 Brings New Blazor Components, Improved Navigation, and WebAssembly
Microsoft has released ASP.NET Core in .NET 11 Preview 1, introducing new Blazor components like EnvironmentBoundary, Label, and DisplayName, along with relative URI navigation, QuickGrid row click ...
Armed with AI coding and data processing tools, the Jmail team has built a suite of web apps for searching through the complex data repository. After officials released millions of pages of documents ...
A lawsuit filed last week alleges tech firm ‘can access virtually all’ private communications, a claim the company has denied US authorities have reportedly investigated claims that Meta can read ...
Two months after .NET 10.0, Microsoft starts preview series for version 11, primarily with innovations in the web frontend framework Blazor.
New Jersey offers a variety of tax relief programs. There's Senior Freeze, Affordable New Jersey Communities for Homeowners and Renters (ANCHOR) and more. And people can now begin submitting ...
The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on ...
More supply chain havoc from the GlassWorm threat has made its way into the software development mix, poisoning software components that have thousands of downstream users. Researchers with ...
An open source AI agent dubbed OpenClaw — formerly MoltBot, née ClawdBot — has become the fastest-growing project on GitHub. But with that popularity has come security concerns. As Token Security ...
NTA declared results of JEE Main 2026, with 12 candidates, including Madhav Viradiya from Maharashtra, scoring 100 percentile ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results